School of Pharmacy
Daniel Berlau, Ph.D., has been an active member of the Biological Sciences section of AACP. He has presented a seminar on team-based learning in the pharmaceutical sciences for the section at the annual meeting in 2014. Dr. Berlau is dedicated to the success of the section, as he worked on the Biological Sciences strategic planning committee and presented its results at the annual meeting in 2014. He just completed a three-year term as secretary for the section, where he learned a lot about how to be an effective section leader. Dr. Berlau is excited for the opportunity to potentially become section chair. His primary goal is to increase communication and interest within the section through networking and the open sharing of ideas.
Dr. Berlau is an associate professor of pharmaceutical sciences at Regis University in Denver, Colo. He earned a Ph.D. in neurobiology and behavior from the University of California, Irvine.
Regis University has an integrated curriculum, and therefore Dr. Berlau is on teaching teams for a variety of disease states. His primary teaching responsibilities are diseases of the GI tract and liver, diseases of the nervous system, and women’s health. His primary responsibility in these teaching teams is to facilitate learning in physiology, pathophysiology and pharmacology.
Dr. Berlau’s research interests are two-fold. He is interested in studying the changes to the brain that accompany aging, especially in diseases such as dementia. His other research interest is the scholarship of teaching and learning, where he is currently examining how student mindset can affect performance in pharmacy school.
Bernard J. Dunn School of Pharmacy
Deepak Bhatia, Ph.D., is the associate professor of pharmacogenomics at Bernard J. Dunn School of Pharmacy. He earned his B.S. degree in pharmacy in 1998 from Bangalore University, India, and his Ph.D. in pharmaceutical sciences in 2007 from West Virginia University School of Pharmacy. During his Ph.D., Dr. Bhatia received a regular fellowship from National Institute of Occupational Safety and Health, a division of Center for Disease Control where he studied occupational hazard of arsenic exposure to lung carcinogenesis in coal miners. Dr. Bhatia also did a postdoctoral fellowship from City of Hope, a comprehensive cancer center, Duarte in California in hematopoietic stem cells and leukemia in 2008.
Dr. Bhatia is also a regular member of AACP, the American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP) and the American Association of Pharmaceutical Scientists (AAPS). Dr. Bhatia serves as an accreditation site evaluator for the Higher Learning Commission (HLC). Dr. Bhatia has published original research papers and authoritative review articles in high-impact, peer-reviewed journals, many book chapters, and presented papers at various national and international scientific meetings. Dr. Bhatia is the editor of epigenetics of chemopreventive drugs for Elsevier, editor of two journals and has acted as guest editor of numerous journal thematic issues. Dr. Bhatia is likewise serving as an editorial board member and ad-hoc reviewer of many reputed journals.